Who is shattuck

Skip to content. On September 15, , the Berkeley City Council renamed Shattuck Avenue East to honor Kala Bagai, an Indian immigrant activist and leader who fought tirelessly against racial prejudice in early 20th century Berkeley.

When Bagai came to the US with her family in , she was one of only a handful of South Asian women in the country, and her arrival to Berkeley was met with hostility and racism. Cal alumna, community activist, and historian Barnali Ghosh M.

It attracts not only the South Asian community in Berkeley, but the wider community as well; the couple never shies away from addressing systems of oppression such as casteism or heterosexism during their tours. The Graduate Wine Collective. Shop CAA. Race and Climate Change. Events Calendar.

On Demand: Alumni Making a Difference. Become a Golden Bears Life Member. Taylor has numerous publications in the field of tumor immunology and immunotherapy, spanning the subjects of cancer vaccines, therapeutic proteins and antibodies, adenosinergic and IDO mediated immunosuppression and regulatory T cell biology.

Taylor received both his M. He received his B. He has more than 25 years of experience in the biotechnology industry. George was most recently Executive Vice President of Business Development for Celgene, where he was responsible for forging collaborations with biotechnology companies seeking to bring breakthrough medications to people suffering from cancer and chronic inflammation. He holds a PhD in genetics from the University of Wisconsin-Madison, and conducted his post-doctoral research in molecular biology at the University of Colorado-Boulder.

Tyler is Managing Director and Portfolio Manager of Lennox Capital Partners, LP, a special situations and value-oriented investment company active in public and private equity.

While at Lennox, Tyler spent over a year working at Arog Pharmaceuticals as the acting CFO, leading their capital markets and business development efforts. Tyler holds a B. Neil has over 25 years of drug development experience and currently serves as chief scientific officer, biologics at COI Pharmaceuticals, where he is responsible for the creation of novel drug discovery companies based on innovative and disruptive technologies. Neil has held various senior positions within the biotechnology and pharmaceutical industry including senior vice president, BioAtla; chief scientific officer, Regulus Therapeutics; chief scientific officer and oncology therapeutic area head, Pfizer Oncology; and chief scientific officer, OSI Pharmaceuticals.

Neil has been involved in the successful discovery, development, and commercialization of four approved oncology drugs, including temozolomide, sorafenib, erlotinib, and crizotinib. While at Regulus he was responsible for leading all research and development efforts resulting in three distinct oligonucleotides being advanced into clinical development and the establishment of human proof of concept with the lead molecule RG He is also a past president of the British Pharmaceutical Students Association.

Neil earned his Ph. By that time Shattuck had died and thus did not witness the vindication of his organizing abilities. Skip to content. Search the site. Found 0 results for your search. Showing 0 to 0. Lemuel Shattuck